Hepatitis B vaccine in
adults with diabetes.
Policy Note: Use of Hepatitis B Vaccine in Adults
with Diabetes Mellitus MMWR 2011;60(50):1709.
Vaccine Information Statement on Hep B
IAC provides a table on
Hepatitis B Prevention Mandates for Daycare and K-12
papers continue WHO’s recommendations for Hep B
vaccine at birth and 2-3 follow-up doses.
WHO also comments on the excellent safety of Hep B
vaccines. Wkly Epi Record 2009;84(40):405.
Protective efficacy, immunotherapeutic potential,
and safety of hepatitis B vaccines.
Zuckerman's review article finds that there is no
evidence of an association between hepatitis B
vaccine and SIDS, MS or Chronic Fatigue Syndrome.
Zuckerman also reports that Hepatitis B vaccines are
among the safest vaccines with few true adverse
reactions. J Med Virol 2006 Feb;78(2):169-77.
IOM Press Release: No Link
Found Between Hepatitis B Vaccine and Certain
Neurological Disorders. (05-30-02)
IOM Report on Hepatitis B Vaccine and
Demyelinating Neurological Disorders.
The Institute of Medicine's Immunization Safety
Review Committee found that the epidemiologic
evidence "favors rejection of a causal
relationship between the hepatitis B vaccine in
adults and multiple sclerosis". (05-30-02)
Balancing Risks and Benefits:
Primum non nocere
Is Too Simplistic.
Neal Halsey and Lynn
Goldman's response to an earlier commentary
regarding the delay of the birth dose of hepatitis B
vaccine. They also include new information
regarding methyl- and ethyl-mercury.
Pediatrics 2001 Aug;108(2):466-7. (08-02-01)
Link to Pediatrics
Studies published in the
New England Journal
of Medicine confirm that hepatitis B vaccine
does not increase risk of multiple sclerosis
Research: No Link Between Vaccines, Risk for MS
to story on WebMD
Preservative-Free Hepatitis B Vaccine
approved by FDA for pediatric and adolescent use
Transverse myelitis not a
recognized vaccine complication
Clarification of Dr.
Kerr's position on hepatitis B vaccine and
transverse myelitis (12-01-99).
New Thimerosal-free Hepatitis
B Vaccine for Use in Infants
On August 27,1999, the FDA approved a
modified hepatitis B vaccine (Recombivax HB)
produced by Merck. The new product is distinguished
from the original by an orange streak on the label
stating "Preservative Free". Use of the new product
should be limited to infants at this time in order
to assure sufficient supplies for all children. MMWR 1999;48(35):780-2.
Hepatitis B Vaccine and Multiple Sclerosis:
A statement prepared by Neal Halsey, MD responding
to the issue of Hepatitis B Vaccine and Multiple
Suspension of Hepatitis B Vaccine in France:
Findings of a meeting in Geneva, Sept 28-30, 1998
Links to other sites for
information on Hepatitis B Vaccine